PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$4.54
+0.09 (+2.02%)
As of Aug 8, 2:17 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +730.6% upside
Low Target $24.55
Average Target $37.71
High Target $48.03
Current Price $4.54
Current
$4.54
Target
$37.71
$24.55 $37.71 avg $48.03
Scenario Analysis
Bear Case
$24.55
440.7%
Low target
Base Case
$37.71
+730.6%
Avg target
Bull Case
$48.03
+957.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.73
-20.8% from high
52-Week Low
$3.06
+48.4% from low
Target vs 52W High
$37.71
+558.1% vs high
Next Earnings Report
Aug 12, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.39
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%